Vanda Pharmaceuticals (VNDA) Cash & Equivalents (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.32% |
| Dec 31, 2025 | 21.18% |
| Sep 30, 2025 | -13.53% |
| Jun 30, 2025 | -27.56% |
| Mar 31, 2025 | 9.27% |
| Dec 31, 2024 | 1.81% |
| Sep 30, 2024 | -2.39% |
| Jun 30, 2024 | -17.74% |
| Mar 31, 2024 | -7.85% |
| Dec 31, 2023 | -25.86% |
| Sep 30, 2023 | 22.10% |
| Jun 30, 2023 | -57.64% |
| Mar 31, 2023 | 162.29% |
| Dec 31, 2022 | 173.35% |
| Sep 30, 2022 | -15.16% |
| Jun 30, 2022 | -13.00% |
| Mar 31, 2022 | 28.53% |
| Dec 31, 2021 | 3.07% |
| Sep 30, 2021 | -11.74% |
| Jun 30, 2021 | -20.64% |
| Mar 31, 2021 | 18.19% |
| Dec 31, 2020 | 7.12% |
| Sep 30, 2020 | -40.22% |
| Jun 30, 2020 | 46.74% |
| Mar 31, 2020 | 44.10% |
| Dec 31, 2019 | 14.96% |
| Sep 30, 2019 | -15.76% |
| Jun 30, 2019 | 35.38% |
| Mar 31, 2019 | -43.65% |
| Dec 31, 2018 | 0.37% |
| Sep 30, 2018 | -0.19% |
| Jun 30, 2018 | -60.79% |
| Mar 31, 2018 | 361.81% |
| Dec 31, 2017 | 48.88% |
| Sep 30, 2017 | 58.70% |
| Jun 30, 2017 | -29.23% |
| Mar 31, 2017 | -80.07% |
| Dec 31, 2016 | 207.99% |
| Sep 30, 2016 | 41.26% |
| Jun 30, 2016 | -40.13% |
| Mar 31, 2016 | -23.80% |
| Dec 31, 2015 | 8.67% |
| Sep 30, 2015 | -3.21% |
| Jun 30, 2015 | 47.33% |
| Mar 31, 2015 | -46.13% |
| Dec 31, 2014 | 297.84% |
| Sep 30, 2014 | -9.92% |
| Jun 30, 2014 | -60.72% |
| Mar 31, 2014 | -33.20% |
| Dec 31, 2013 | -54.45% |
| Sep 30, 2013 | 37.19% |
| Jun 30, 2013 | -5.73% |
| Mar 31, 2013 | 23.84% |
| Dec 31, 2012 | -15.06% |
| Sep 30, 2012 | 10.73% |
| Jun 30, 2012 | -12.68% |
| Mar 31, 2012 | 22.94% |
| Dec 31, 2011 | 45.75% |
| Sep 30, 2011 | 19.73% |
| Jun 30, 2011 | -4.06% |
| Mar 31, 2011 | 23.41% |
| Dec 31, 2010 | -58.47% |
| Sep 30, 2010 | -29.65% |